Literature DB >> 26097505

On the relative role of different age groups in influenza epidemics.

Colin J Worby1, Sandra S Chaves2, Jacco Wallinga3, Marc Lipsitch4, Lyn Finelli2, Edward Goldstein1.   

Abstract

The identification of key "driver" groups in influenza epidemics is of much interest for the implementation of effective public health response strategies, including vaccination programs. However, the relative importance of different age groups in propagating epidemics is uncertain. During a communicable disease outbreak, some groups may be disproportionately represented during the outbreak's ascent due to increased susceptibility and/or contact rates. Such groups or subpopulations can be identified by considering the proportion of cases within the subpopulation occurring before (Bp) and after the epidemic peak (Ap) to calculate the subpopulation's relative risk, RR=Bp/Ap. We estimated RR for several subpopulations (age groups) using data on laboratory-confirmed US influenza hospitalizations during epidemics between 2009-2014. Additionally, we simulated various influenza outbreaks in an age-stratified population, relating the RR to the impact of vaccination in each subpopulation on the epidemic's initial effective reproductive number R_e(0). We found that children aged 5-17 had the highest estimates of RR during the five largest influenza A outbreaks, though the relative magnitude of RR in this age group compared to other age groups varied, being highest for the 2009 A/H1N1 pandemic. For the 2010-2011 and 2012-2013 influenza B epidemics, adults aged 18-49, and 0-4 year-olds had the highest estimates of RR respectively. For 83% of simulated epidemics, the group with the highest RR was also the group for which initial distribution of a given quantity of vaccine would result in the largest reduction of R_e(0). In the largest 40% of simulated outbreaks, the group with the highest RR and the largest vaccination impact was children 5-17. While the relative importance of different age groups in propagating influenza outbreaks varies, children aged 5-17 play the leading role during the largest influenza A epidemics. Extra vaccination efforts for this group may contribute to reducing the epidemic's impact in the whole community.

Entities:  

Year:  2015        PMID: 26097505      PMCID: PMC4469206          DOI: 10.1016/j.epidem.2015.04.003

Source DB:  PubMed          Journal:  Epidemics        ISSN: 1878-0067            Impact factor:   4.396


  24 in total

1.  Mid-season influenza vaccine effectiveness 2011-2012: a Department of Defense Global, Laboratory-based, Influenza Surveillance System case-control study estimate.

Authors:  Victor H MacIntosh; Katie J Tastad; Angelia A Eick-Cost
Journal:  Vaccine       Date:  2013-02-06       Impact factor: 3.641

2.  Tecumseh study of illness. XIII. Influenza infection and disease, 1976-1981.

Authors:  A S Monto; J S Koopman; I M Longini
Journal:  Am J Epidemiol       Date:  1985-06       Impact factor: 4.897

3.  The Japanese experience with vaccinating schoolchildren against influenza.

Authors:  T A Reichert; N Sugaya; D S Fedson; W P Glezen; L Simonsen; M Tashiro
Journal:  N Engl J Med       Date:  2001-03-22       Impact factor: 91.245

4.  Different transmission patterns in the early stages of the influenza A(H1N1)v pandemic: a comparative analysis of 12 European countries.

Authors:  Stefan Flasche; Niel Hens; Pierre-Yves Boëlle; Joël Mossong; W Marijn van Ballegooijen; Baltazar Nunes; Caterina Rizzo; Florin Popovici; Patricia Santa-Olalla; Frantiska Hrubá; Kremena Parmakova; Marc Baguelin; Albert Jan van Hoek; Jean-Claude Desenclos; Pascale Bernillon; Amparro Larrauri Cámara; Jacco Wallinga; Tommi Asikainen; Peter J White; W John Edmunds
Journal:  Epidemics       Date:  2011-04-13       Impact factor: 4.396

5.  Optimizing infectious disease interventions during an emerging epidemic.

Authors:  Jacco Wallinga; Michiel van Boven; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

6.  Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty.

Authors:  Martial L Ndeffo Mbah; Jan Medlock; Lauren Ancel Meyers; Alison P Galvani; Jeffrey P Townsend
Journal:  Vaccine       Date:  2013-05-16       Impact factor: 3.641

7.  Estimating the impact of school closure on influenza transmission from Sentinel data.

Authors:  Simon Cauchemez; Alain-Jacques Valleron; Pierre-Yves Boëlle; Antoine Flahault; Neil M Ferguson
Journal:  Nature       Date:  2008-04-10       Impact factor: 49.962

8.  Age-specific differences in influenza A epidemic curves: do children drive the spread of influenza epidemics?

Authors:  Dena Schanzer; Julie Vachon; Louise Pelletier
Journal:  Am J Epidemiol       Date:  2011-05-20       Impact factor: 4.897

9.  Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City.

Authors:  Donald R Olson; Richard T Heffernan; Marc Paladini; Kevin Konty; Don Weiss; Farzad Mostashari
Journal:  PLoS Med       Date:  2007-08       Impact factor: 11.069

10.  Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.

Authors:  Nicole E Basta; Dennis L Chao; M Elizabeth Halloran; Laura Matrajt; Ira M Longini
Journal:  Am J Epidemiol       Date:  2009-08-13       Impact factor: 4.897

View more
  49 in total

Review 1.  Temporally Varying Relative Risks for Infectious Diseases: Implications for Infectious Disease Control.

Authors:  Edward Goldstein; Virginia E Pitzer; Justin J O'Hagan; Marc Lipsitch
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

2.  High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses.

Authors:  Jin Hyang Kim; H Keipp Talbot; Margarita Mishina; Yuwei Zhu; Jufu Chen; Weiping Cao; Adrian J Reber; Marie R Griffin; David K Shay; Sarah M Spencer; Suryaprakash Sambhara
Journal:  Vaccine       Date:  2016-07-26       Impact factor: 3.641

3.  Estimating age-specific reproductive numbers-A comparison of methods.

Authors:  Carlee B Moser; Laura F White
Journal:  Stat Methods Med Res       Date:  2016-10-17       Impact factor: 3.021

4.  Incorporating social contact data in spatio-temporal models for infectious disease spread.

Authors:  Sebastian Meyer; Leonhard Held
Journal:  Biostatistics       Date:  2017-04-01       Impact factor: 5.899

5.  Socioeconomic and environmental patterns behind H1N1 spreading in Sweden.

Authors:  András Bota; Martin Holmberg; Lauren Gardner; Martin Rosvall
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

6.  On the Relative Role of Different Age Groups During Epidemics Associated With Respiratory Syncytial Virus.

Authors:  Edward Goldstein; Hieu H Nguyen; Patrick Liu; Cecile Viboud; Claudia A Steiner; Colin J Worby; Marc Lipsitch
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

7.  Association Between Statewide School Closure and COVID-19 Incidence and Mortality in the US.

Authors:  Katherine A Auger; Samir S Shah; Troy Richardson; David Hartley; Matthew Hall; Amanda Warniment; Kristen Timmons; Dianna Bosse; Sarah A Ferris; Patrick W Brady; Amanda C Schondelmeyer; Joanna E Thomson
Journal:  JAMA       Date:  2020-09-01       Impact factor: 56.272

8.  The COVID-19 Pandemic and Changes in Healthcare Utilization for Pediatric Respiratory and Nonrespiratory Illnesses in the United States.

Authors:  James W Antoon; Derek J Williams; Cary Thurm; Michael Bendel-Stenzel; Alicen B Spaulding; Ronald J Teufel; Mario A Reyes; Samir S Shah; Chén C Kenyon; Adam L Hersh; Todd A Florin; Carlos G Grijalva
Journal:  J Hosp Med       Date:  2021-05       Impact factor: 2.960

Review 9.  Influenza Virus and SARS-CoV-2 Vaccines.

Authors:  Adam M Sandor; Michael S Sturdivant; Jenny P Y Ting
Journal:  J Immunol       Date:  2021-05-21       Impact factor: 5.426

10.  Action and Reaction of Pre-Primary and Primary School-Age Children to Restrictions during COVID-19 Pandemic in Greece.

Authors:  Dimitra I Siachpazidou; Ourania S Kotsiou; Grigorios Chatziparasidis; Dimitrios Papagiannis; George D Vavougios; Eudoxia Gogou; Vasileios T Stavrou; Konstantinos I Gourgoulianis
Journal:  J Pers Med       Date:  2021-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.